The Role of Glucocorticoids in Development and Function of the Endocrine Pancreas

描述（由申请人提供）：本建议书概述了候选人Ronadip R的五年综合培训计划。Banerjee，医学博士，哲学博士、在他作为一个医生科学家的发展成为一个独立的调查员。Banerjee博士的研究计划，调查糖皮质激素在内分泌胰腺发育和功能中的作用，将在斯坦福大学发育生物学教授和霍华德休斯研究员Seung Kim博士的实验室进行。该研究计划探讨了糖皮质激素通过抑制生长、抑制激素分泌和基因表达来调节内分泌胰腺的发育和功能的假设。这一假设通过三个具体目标进行评估：（1）确定GC在内分泌胰腺发育和出生后扩张中的作用，（2）阐明出生后和成年期胰岛中GC信号传导失活的代谢后果，以及（3）通过使用代谢应激反应的环境和药理学模型，糖皮质激素过量为了实现这些目标，该项目使用“Cre-Lox”系统在小鼠中生成条件性“敲除”遗传模型。代谢表型，结合专门的细胞和分子分析，将确定在分子水平上的细胞类型特异性条件性GR缺失的生理后果。这些目标的实现应确定糖皮质激素如何直接调节胰岛生长和功能。此外，该项目应提供深入了解糖皮质激素诱导的糖尿病的分子基础，并确定可能在糖尿病治疗中提出新的治疗靶点的特定分子缺陷。同时，Banerjee博士将完成由斯坦福大学内分泌和代谢部门的领先医生科学家和导师组成的咨询委员会监督的结构化职业发展培训。这些将包括必要的教学，临床，教学和管理经验，以实现他的长期目标，成为一个全面的医生，科学家能够运行在领先的学术医疗中心的研究实验室。 公共卫生相关性：糖尿病，在今天的美国折磨着多达2500万人，是死亡和发病的主要原因，包括失明、心脏病、中风和肾病。显然，这是一个重大的公共卫生问题。糖尿病的主要缺陷之一是胰腺不能产生足够的胰岛素来匹配增加的血糖水平。我们的建议调查了“压力”激素，称为糖皮质激素，如何直接破坏胰腺细胞的正常生长和功能。了解这一过程可能会导致专门针对胰腺功能障碍的新疗法，这是糖尿病疾病过程的基石。

DESCRIPTION (provided by applicant): This proposal outlines an integrative five year training program for the candidate, Ronadip R. Banerjee, M.D., Ph.D., in his development as a physician-scientist towards becoming an independent investigator. Dr. Banerjee's research proposal, investigating the role of glucocorticoids in the development and function of the endocrine pancreas, will be carried out in the laboratory of Dr. Seung Kim, Professor of Developmental Biology and Howard Hughes Investigator at Stanford University. The research plan explores the hypothesis that glucocorticoids regulate the development and function of the endocrine pancreas by inhibiting growth, and suppressing hormone secretion and gene expression. This hypothesis is evaluated by three Specific Aims: (1) to determine the role of GCs in the development and postnatal expansion of the endocrine pancreas, (2) to elucidate the metabolic consequences of inactivating GC signaling in islets in postnatal and adult periods, and (3) to evaluate the consequences of abolishing GC signaling in islets to the metabolic stress response by using environmental and pharmacologic models of glucocorticoid excess. To accomplish these Aims, the project uses the "Cre-Lox" system to generate conditional "knockout" genetic models in mice. Metabolic phenotyping, in conjunction with specialized cell and molecular analyses will ascertain the physiologic consequences of the cell-type-specific conditional deletion of GR at a molecular level. Accomplishment of these Aims should identify how glucocorticoids directly regulate islet growth and function. Additionally, this project should provide insight into the molecular underpinnings of glucocorticoid-induced diabetes, and identify specific molecular defects that may present novel therapeutic targets in diabetes treatment. Concurrently, Dr. Banerjee will complete structured career development training supervised by an Advisory Committee comprised of leading physician-scientists and mentors within the Stanford Endocrinology and Metabolism division. These will include didactic, clinical, teaching, and managerial experience necessary to achieve his long-term goal of becoming a well-rounded physician-scientist capable of running a research laboratory at a leading academic medical center. PUBLIC HEALTH RELEVANCE: Diabetes, which afflicts as many as 25 million people in the United States today, is a leading cause of death, and morbidity, including blindness, heart disease, stroke, and kidney disease. Clearly, it is a major public health problem. One of the major defects in diabetes is the failure of the pancreas to produce enough insulin to match the increased blood glucose levels. Our proposal investigates how "stress" hormones, called glucocorticoids, might directly disrupt the normal growth and function of the hormone-producing cells of the pancreas. Understanding this process may lead to new therapies directed specifically at the pancreas dysfunction that is a cornerstone of the diabetic disease process.